Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 30% ± 15% | |
peripheral blood | 17 studies | 35% ± 11% | |
brain | 13 studies | 32% ± 17% | |
intestine | 9 studies | 24% ± 11% | |
kidney | 5 studies | 22% ± 4% | |
heart | 5 studies | 21% ± 2% | |
liver | 5 studies | 37% ± 18% | |
bone marrow | 4 studies | 30% ± 8% | |
eye | 4 studies | 28% ± 14% | |
uterus | 4 studies | 32% ± 14% | |
lymph node | 4 studies | 27% ± 4% | |
adipose | 4 studies | 25% ± 5% | |
placenta | 3 studies | 38% ± 8% | |
breast | 3 studies | 17% ± 0% | |
esophagus | 3 studies | 34% ± 21% | |
skin | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 4952.14 | 21 / 21 | 100% | 179.75 | 504 / 504 |
breast | 100% | 5416.15 | 459 / 459 | 100% | 191.81 | 1118 / 1118 |
ovary | 100% | 3715.49 | 180 / 180 | 100% | 133.01 | 430 / 430 |
prostate | 100% | 4922.82 | 245 / 245 | 100% | 110.61 | 502 / 502 |
esophagus | 100% | 6984.00 | 1444 / 1445 | 100% | 160.29 | 183 / 183 |
lung | 100% | 8176.47 | 578 / 578 | 100% | 178.63 | 1154 / 1155 |
intestine | 100% | 5873.79 | 966 / 966 | 100% | 166.09 | 526 / 527 |
stomach | 100% | 4151.06 | 359 / 359 | 100% | 151.68 | 285 / 286 |
uterus | 100% | 4400.56 | 170 / 170 | 99% | 189.40 | 456 / 459 |
thymus | 100% | 5307.84 | 653 / 653 | 99% | 125.31 | 601 / 605 |
skin | 100% | 9871.04 | 1809 / 1809 | 99% | 155.40 | 465 / 472 |
kidney | 100% | 4096.19 | 89 / 89 | 97% | 105.81 | 878 / 901 |
brain | 99% | 3336.63 | 2605 / 2642 | 99% | 80.74 | 696 / 705 |
pancreas | 99% | 2997.37 | 325 / 328 | 98% | 140.44 | 174 / 178 |
liver | 100% | 3629.29 | 226 / 226 | 95% | 68.58 | 386 / 406 |
adrenal gland | 100% | 5449.41 | 258 / 258 | 92% | 52.91 | 212 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 234.44 | 29 / 29 |
spleen | 100% | 11377.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 200.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 92.19 | 1 / 1 |
adipose | 100% | 6184.35 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 15475.02 | 923 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 4102.39 | 1326 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 187.54 | 79 / 80 |
heart | 91% | 2353.56 | 785 / 861 | 0% | 0 | 0 / 0 |
muscle | 86% | 2130.02 | 693 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0051016 | Biological process | barbed-end actin filament capping |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0034329 | Biological process | cell junction assembly |
GO_0008290 | Cellular component | F-actin capping protein complex |
GO_0030863 | Cellular component | cortical cytoskeleton |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0071203 | Cellular component | WASH complex |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0045296 | Molecular function | cadherin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | CAPZA1 |
Protein name | F-actin-capping protein subunit alpha-1 (CapZ alpha-1) |
Synonyms | |
Description | FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the formation of epithelial cell junctions . Forms, with CAPZB, the barbed end of the fast growing ends of actin filaments in the dynactin complex and stabilizes dynactin structure. The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). . |
Accessions | ENST00000263168.4 P52907 |